Translated from our German original by AI. The German text was researched, written, and edited by the Psychedelia Foundation team and remains the authoritative version.
A recent commentary calls for indigenous communities to take a stronger and equal part in psychedelic research. Its authors argue that the knowledge these communities have built up over generations about psychoactive plants and fungi has so far been given too little weight in scientific debate. Among the problems they name are extractive research, commercialization, and the exclusion of indigenous actors from political decision-making.
Drawing on ayahuasca, psilocybin, peyote and ibogaine, the authors point to traditional knowledge systems in which the use of psychoactive substances is embedded in ritual, communal and ecological contexts. Such perspectives, they suggest, could yield important insights for research into safety and efficacy.
Their demands include free, prior and informed consent from indigenous communities, protection of cultural and intellectual property rights, and a fair share in any benefits arising from research and commercial use. Indigenous representatives should also not be included symbolically, but given a real role in research, governance and policy decisions.
As one possible approach the authors propose formalized and transparent international dialogue processes that bring indigenous representatives, science and policymakers together, citing the global consultation processes of the World Health Organization as an example. The aim would be psychedelic research that holds to scientific quality while also taking account of the rights and perspectives of indigenous communities.